Literature DB >> 16452413

The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages.

Willem J B van Wamel1, Suzan H M Rooijakkers, Maartje Ruyken, Kok P M van Kessel, Jos A G van Strijp.   

Abstract

Two newly discovered immune modulators, chemotaxis inhibitory protein of Staphylococcus aureus (CHIPS) and staphylococcal complement inhibitor (SCIN), cluster on the conserved 3' end of beta-hemolysin (hlb)-converting bacteriophages (betaC-phis). Since these betaC-phis also carry the genes for the immune evasion molecules staphylokinase (sak) and enterotoxin A (sea), this 8-kb region at the 3' end of betaC-phi represents an innate immune evasion cluster (IEC). By PCR and Southern analyses of 85 clinical Staphylococcus aureus strains and 5 classical laboratory strains, we show that 90% of S. aureus strains carry a betaC-phi with an IEC. Seven IEC variants were discovered, carrying different combinations of chp, sak, or sea (or sep), always in the same 5'-to-3' orientation and on the 3' end of a betaC-phi. From most IEC variants we could isolate active bacteriophages by mitomycin C treatment, of which lysogens were generated in S. aureus R5 (broad phage host). All IEC-carrying bacteriophages integrated into hlb, as was measured by Southern blotting of R5 lysogens. Large quantities of the different bacteriophages were obtained by mitomycin C treatment of the lysogens, and bacteriophages were collected and used to reinfect all lysogenic R5 strains. In total, five lytic families were found. Furthermore, phage DNA was isolated and digested with EcoR1, revealing that one IEC variant can be found on different betaI-phis. In conclusion, the four human-specific innate immune modulators SCIN, CHIPS, SAK, and SEA form an IEC that is easily transferred among S. aureus strains by a diverse group of beta-hemolysin-converting bacteriophages.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452413      PMCID: PMC1367213          DOI: 10.1128/JB.188.4.1310-1315.2006

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  30 in total

1.  Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.

Authors:  Suzan H M Rooijakkers; Maartje Ruyken; Anja Roos; Mohamed R Daha; Julia S Presanis; Robert B Sim; Willem J B van Wamel; Kok P M van Kessel; Jos A G van Strijp
Journal:  Nat Immunol       Date:  2005-08-07       Impact factor: 25.606

2.  Sau42I, a BcgI-like restriction-modification system encoded by the Staphylococcus aureus quadruple-converting phage Phi42.

Authors:  Rita M Dempsey; David Carroll; Huimin Kong; Lauren Higgins; Conor T Keane; David C Coleman
Journal:  Microbiology       Date:  2005-04       Impact factor: 2.777

3.  Whole genome sequencing of meticillin-resistant Staphylococcus aureus.

Authors:  M Kuroda; T Ohta; I Uchiyama; T Baba; H Yuzawa; I Kobayashi; L Cui; A Oguchi; K Aoki; Y Nagai; J Lian; T Ito; M Kanamori; H Matsumaru; A Maruyama; H Murakami; A Hosoyama; Y Mizutani-Ui; N K Takahashi; T Sawano; R Inoue; C Kaito; K Sekimizu; H Hirakawa; S Kuhara; S Goto; J Yabuzaki; M Kanehisa; A Yamashita; K Oshima; K Furuya; C Yoshino; T Shiba; M Hattori; N Ogasawara; H Hayashi; K Hiramatsu
Journal:  Lancet       Date:  2001-04-21       Impact factor: 79.321

4.  Anti-opsonic properties of staphylokinase.

Authors:  S H M Rooijakkers; W J B van Wamel; M Ruyken; K P M van Kessel; J A G van Strijp
Journal:  Microbes Infect       Date:  2005-02-26       Impact factor: 2.700

5.  Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease.

Authors:  Sophie Jarraud; Christophe Mougel; Jean Thioulouse; Gerard Lina; Hélène Meugnier; Françoise Forey; Xavier Nesme; Jerome Etienne; François Vandenesch
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT.

Authors:  S Narita; J Kaneko; J Chiba; Y Piémont; S Jarraud; J Etienne; Y Kamio
Journal:  Gene       Date:  2001-05-02       Impact factor: 3.688

7.  An exfoliative toxin A-converting phage isolated from Staphylococcus aureus strain ZM.

Authors:  Y Yoshizawa; J Sakurada; S Sakurai; K Machida; I Kondo; S Masuda
Journal:  Microbiol Immunol       Date:  2000       Impact factor: 1.955

8.  Prophage, phiPV83-pro, carrying panton-valentine leukocidin genes, on the Staphylococcus aureus P83 chromosome: comparative analysis of the genome structures of phiPV83-pro, phiPVL, phi11, and other phages.

Authors:  D Zou; J Kaneko; S Narita; Y Kamio
Journal:  Biosci Biotechnol Biochem       Date:  2000-12       Impact factor: 2.043

9.  Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance.

Authors:  Matthew T G Holden; Edward J Feil; Jodi A Lindsay; Sharon J Peacock; Nicholas P J Day; Mark C Enright; Tim J Foster; Catrin E Moore; Laurence Hurst; Rebecca Atkin; Andrew Barron; Nathalie Bason; Stephen D Bentley; Carol Chillingworth; Tracey Chillingworth; Carol Churcher; Louise Clark; Craig Corton; Ann Cronin; Jon Doggett; Linda Dowd; Theresa Feltwell; Zahra Hance; Barbara Harris; Heidi Hauser; Simon Holroyd; Kay Jagels; Keith D James; Nicola Lennard; Alexandra Line; Rebecca Mayes; Sharon Moule; Karen Mungall; Douglas Ormond; Michael A Quail; Ester Rabbinowitsch; Kim Rutherford; Mandy Sanders; Sarah Sharp; Mark Simmonds; Kim Stevens; Sally Whitehead; Bart G Barrell; Brian G Spratt; Julian Parkhill
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-22       Impact factor: 11.205

10.  Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.

Authors:  Carla J C de Haas; Karin Ellen Veldkamp; Andreas Peschel; Floor Weerkamp; Willem J B Van Wamel; Erik C J M Heezius; Miriam J J G Poppelier; Kok P M Van Kessel; Jos A G van Strijp
Journal:  J Exp Med       Date:  2004-03-01       Impact factor: 14.307

View more
  222 in total

Review 1.  Immunopathology of mastitis: insights into disease recognition and resolution.

Authors:  Stacey L Aitken; Christine M Corl; Lorraine M Sordillo
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-09-22       Impact factor: 2.673

2.  Detection of mobile-genetic-element variation between colonizing and infecting hospital-associated methicillin-resistant Staphylococcus aureus isolates.

Authors:  Alex J McCarthy; Aodhan S Breathnach; Jodi A Lindsay
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

3.  DNA microarray genotyping and virulence and antimicrobial resistance gene profiling of methicillin-resistant Staphylococcus aureus bloodstream isolates from renal patients.

Authors:  Sinead McNicholas; Anna C Shore; David C Coleman; Hilary Humphreys; Deirdre Fitzgerald Hughes
Journal:  J Clin Microbiol       Date:  2011-09-21       Impact factor: 5.948

Review 4.  Staphylococcal manipulation of host immune responses.

Authors:  Vilasack Thammavongsa; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Nat Rev Microbiol       Date:  2015-09       Impact factor: 60.633

5.  Methicillin-resistant Staphylococcus aureus in commercial swine herds is associated with disinfectant and zinc usage.

Authors:  Mackenzie Jonathan Slifierz; Robert M Friendship; J Scott Weese
Journal:  Appl Environ Microbiol       Date:  2015-02-06       Impact factor: 4.792

6.  Epidemiology of invasive methicillin-resistant Staphylococcus aureus clones collected in France in 2006 and 2007.

Authors:  Olivier Dauwalder; Gérard Lina; Géraldine Durand; Michèle Bes; Hélène Meugnier; Vincent Jarlier; Bruno Coignard; François Vandenesch; Jerome Etienne; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2008-07-30       Impact factor: 5.948

7.  Extensive genetic diversity identified among sporadic methicillin-resistant Staphylococcus aureus isolates recovered in Irish hospitals between 2000 and 2012.

Authors:  Peter M Kinnevey; Anna C Shore; Grainne I Brennan; Derek J Sullivan; Ralf Ehricht; Stefan Monecke; David C Coleman
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

8.  Characterisation of MRSA from Malta and the description of a Maltese epidemic MRSA strain.

Authors:  E A Scicluna; A C Shore; A Thürmer; R Ehricht; P Slickers; M A Borg; D C Coleman; S Monecke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-13       Impact factor: 3.267

9.  Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureus.

Authors:  Michael S Calderwood; Christopher A Desjardins; George Sakoulas; Robert Nicol; Andrea Dubois; Mary L Delaney; Ken Kleinman; Lisa A Cosimi; Michael Feldgarden; Andrew B Onderdonk; Bruce W Birren; Richard Platt; Susan S Huang
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

10.  Comparative genomics and transduction potential of Enterococcus faecalis temperate bacteriophages.

Authors:  Azra Yasmin; John G Kenny; Jayendra Shankar; Alistair C Darby; Neil Hall; Clive Edwards; Malcolm J Horsburgh
Journal:  J Bacteriol       Date:  2009-12-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.